On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Private Equity Round – Spiber
On Sep 8, 2021 Spiber closed a Private Equity round and raised ¥24,400,000,000 from Baillie Gifford, Cool Japan Fund, Fidelity International, Satake Chemical Machinery, The […]
Series A – A-Alpha Bio
On Sep 8, 2021 A-Alpha Bio closed a Series A round and raised $20,000,000 from Lux Capital, Madrona Venture Group, Perceptive Advisors, featuring lead investors […]
Post-IPO Equity – Biostage
On Sep 8, 2021 Biostage closed a Post-IPO Equity round and raised $2,600,000 from investors, featuring lead investors . About the company: Biostage is located […]
Venture Round – Haemalogix
On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management. […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – PetMedix
On Sep 8, 2021 PetMedix closed a Series B round and raised £27,000,000 from Cambridge Innovation Capital, Digitalis Ventures, Kyoritsu Corporation, Parkwalk Advisors, Tencent, featuring […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Series D – INBRACE
On Sep 8, 2021 INBRACE closed a Series D round and raised $102,000,000 from BlackRock, Endeavour Vision, Farallon Capital Management, Marshall Wace, MVM Life Science […]
